|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q3 FY2020
As of Sep 30, 2020
|
Q2 FY2020
As of Jun 30, 2020
|
Q1 FY2020
As of Mar 31, 2020
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Investments: | ||||||||||||||||||||
| Fixed maturities available-for-sale, at fair value (amortized cost of $61,728 and $61,884) (allowance for credit losses of $2 and $4) | ||||||||||||||||||||
| Mortgage loans on real estate (net of allowance for credit losses of $270 and $277) | ||||||||||||||||||||
| Policy loans | ||||||||||||||||||||
| Other equity investments | ||||||||||||||||||||
| Trading securities, at fair value | ||||||||||||||||||||
| Other invested assets | ||||||||||||||||||||
| Total investments | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Deferred policy acquisition costs | ||||||||||||||||||||
| Amounts due from reinsurers (allowance for credit losses of $8 and $7) | ||||||||||||||||||||
| Loans to affiliates | ||||||||||||||||||||
| GMIB reinsurance contract asset, at fair value | ||||||||||||||||||||
| Current and deferred income taxes | ||||||||||||||||||||
| Purchased market risk benefits | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Assets for market risk benefits | ||||||||||||||||||||
| Separate Accounts assets | ||||||||||||||||||||
| Total Assets | ||||||||||||||||||||
| LIABILITIES | ||||||||||||||||||||
| Policyholders’ account balances | ||||||||||||||||||||
| Liability for market risk benefits | ||||||||||||||||||||
| Future policy benefits and other policyholders' liabilities | ||||||||||||||||||||
| Broker-dealer related payables | ||||||||||||||||||||
| Amounts due to reinsurers | ||||||||||||||||||||
| Current and deferred income taxes | ||||||||||||||||||||
| Funds withheld payable | ||||||||||||||||||||
| Loans from affiliates | ||||||||||||||||||||
| Reinsurance deposit liabilities | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Separate Accounts liabilities | ||||||||||||||||||||
| Total Liabilities | ||||||||||||||||||||
| Redeemable noncontrolling interest | ||||||||||||||||||||
| EQUITY | ||||||||||||||||||||
| Equity attributable to Equitable Financial: | ||||||||||||||||||||
| Common stock, $1.25 par value; 2,000,000 shares authorized, issued and outstanding | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Accumulated other comprehensive income (loss) | ||||||||||||||||||||
| Total equity attributable to Equitable Financial | ||||||||||||||||||||
| Noncontrolling interest | ||||||||||||||||||||
| Total Equity | ||||||||||||||||||||
| Total Liabilities, Redeemable Noncontrolling Interest and Equity | ||||||||||||||||||||
Loading...
